Dr. Hong Zhao 赵宏
Chief Physician
Department of Hepatobiliary Surgery, Cancer Hospital, Chinese Academy of Medical Sciences (National Cancer Center), Beijing
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Surgical and multidisciplinary treatment of gastrointestinal, liver, breast, and pancreatic tumors. Specializes in surgery for colorectal cancer with liver metastases, neuroendocrine tumors, and hepatocellular carcinoma.
Dr. Zhao earned a medical doctorate from Peking Union Medical College in 2003. A Chief Physician and master’s supervisor, Dr. Zhao serves as Deputy Director of the Hepatobiliary Surgery Department at the Cancer Hospital, Chinese Academy of Medical Sciences. Dr. Zhao has led or participated in multiple national research projects and published over 10 academic papers.
Professional roles
- Secretary-General, Neuroendocrine Tumor Branch, China International Exchange and Promotion Association for Medical and Healthcare
- Vice Chair, Youth Committee, Oncology Branch, Beijing Medical Association
- Director-General, Youth Committee, Liver Tumor Branch, China International Exchange and Promotion Association for Medical and Healthcare
Name order: in Chinese the family name comes first (Zhao Hong). Papers usually list the name as Hong Zhao or Zhao H.
Selected publications
218 papers on PubMed matched by name and affiliation; 47 as first or senior author since 2016. Most recent first- or senior-author papers:
- Cancer Res, 2026 (senior author): Cross-talk between Schwann Cells and CD4+ T Cells Promotes Perineural Invasion in Colorectal Cancer. PubMed 42489533
- Am J Cancer Res, 2026 (senior author): NDUFA12 is associated with poor prognosis and promotes malignant phenotypes and mitochondrial metabolic alterations in hepatocellular carcinoma. PubMed 42465020
- NPJ Digit Med, 2026 (senior author): Impact of an AI prognostic tool on clinician performance in colorectal liver metastases. PubMed 41951838
- MedComm (2020), 2026 (senior author): Landscape of Somatic and Age-Related Pathogenic Structural Variations in Hepatocellular Carcinoma Revealed by Long-Read Sequencing. PubMed 41536518
- Asia Pac J Oncol Nurs, 2025 (senior author): Exploring the mediating roles of stigma and perceived social support between health literacy and health care decision-making barriers among patients with cervical cancer. PubMed 40503356
- Exp Mol Med, 2025 (senior author): Single-cell transcriptomic profiling reveals liver fibrosis in colorectal cancer liver metastasis. PubMed 41258075
- Eur J Surg Oncol, 2025 (senior author): Pre-treatment S-index as a promising prognostic indicator of treatment response and survival in patients with synchronous colorectal liver metastases: A retrospective multi-center study. PubMed 40907168
- Front Med, 2025 (senior author): Precision medicine for advanced biliary tract cancer in China: current status and future perspectives. PubMed 41087790
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital. This name is shared by other researchers, so we checked that the papers match this doctor's specialty; this check is automatic.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion